Gertz Morie A
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
Leuk Lymphoma. 2007 Mar;48(3):458-68. doi: 10.1080/10428190601059753.
The new International Staging System should be reported in all future studies of multiple myeloma. However, the system fails to account for recent research findings pertaining to mechanisms of disease progression. This review describes development of the International Staging System and details prognostic factors that may further our understanding of the biology of multiple myeloma.
所有未来的多发性骨髓瘤研究均应报告新的国际分期系统。然而，该系统未能考虑到与疾病进展机制相关的最新研究发现。本综述描述了国际分期系统的发展，并详述了可能增进我们对多发性骨髓瘤生物学理解的预后因素。
